首页> 外文学位 >Function of MicroRNA-146a and NF-kappaB in Physiologic and Pathologic Hematopoiesis.
【24h】

Function of MicroRNA-146a and NF-kappaB in Physiologic and Pathologic Hematopoiesis.

机译:MicroRNA-146a和NF-kappaB在生理和病理造血中的功能。

获取原文
获取原文并翻译 | 示例

摘要

During inflammation and infection, hematopoietic stem and progenitor cells (HSPCs) are stimulated to proliferate and differentiate into mature immune cells, especially of the myeloid lineage. MicroRNA-146a (miR-146a) is a critical negative regulator of inflammation. Deletion of the gene encoding miR-146a---expressed in all blood cell types---produces effects that appear as dysregulated inflammatory hematopoiesis, leading to a decline in the number and quality of hematopoietic stem cells (HSCs), excessive myeloproliferation, and, ultimately, to exhaustion of the HSCs and hematopoietic neoplasms. Six-week-old deleted mice are normal, with no effect on cell numbers, but by 4 months bone marrow hypercellularity can be seen, and by 8 months marrow exhaustion is becoming evident. The ability of HSCs to replenish the entire hematopoietic repertoire in a myelo-ablated mouse also declines precipitously as miR-146a-deficient mice age. In the absence of miR-146a, LPS-mediated serial inflammatory stimulation accelerates the effects of aging. This chronic inflammatory stress on HSCs in deleted mice involves a molecular axis consisting of upregulation of the signaling protein TRAF6 leading to excessive activity of the transcription factor NF-kappaB and overproduction of the cytokine IL-6. At the cellular level, transplant studies show that the defects are attributable to both an intrinsic problem in the miR-146a-deficient HSCs and extrinsic effects of miR-146a-deficient lymphocytes and non-hematopoietic cells. This study has identified a microRNA, miR-146a, to be a critical regulator of HSC homeostasis during chronic inflammatory challenge in mice and has provided a molecular connection between chronic inflammation and the development of bone marrow failure and myeloproliferative neoplasms. This may have implications for human hematopoietic malignancies, such as myelodysplastic syndrome, which frequently displays downregulated miR-146a expression.
机译:在炎症和感染过程中,造血干细胞和祖细胞(HSPC)被刺激增殖并分化为成熟的免疫细胞,特别是髓系。 MicroRNA-146a(miR-146a)是炎症的关键负调节剂。在所有血细胞类型中表达的编码miR-146a的基因的缺失都会产生炎症性造血功能失调,从而导致造血干细胞(HSC)数量和质量下降,骨髓过度增殖以及最终导致HSC和造血肿瘤的衰竭。六周大的删除小鼠是正常的,对细胞数量没有影响,但是到4个月时,可以看到骨髓细胞过多,到8个月时,骨髓衰竭就变得很明显。随着miR-146a缺陷小鼠的衰老,HSC补充骨髓消融小鼠中整个造血库的能力也急剧下降。在没有miR-146a的情况下,LPS介导的系列炎症刺激会加速衰老。在缺失的小鼠中,HSC的这种慢性炎症性应激涉及一个分子轴,该分子轴由信号蛋白TRAF6的上调引起转录因子NF-κB的过度活性和细胞因子IL-6的过量生产。在细胞水平上,移植研究表明,缺陷既可归因于miR-146a缺陷型HSC的内在问题,也归因于miR-146a缺陷型淋巴细胞和非造血细胞的外在作用。这项研究已经确定了miR-146a microRNA在小鼠慢性炎症攻击过程中是HSC稳态的关键调节剂,并提供了慢性炎症与骨髓衰竭和骨髓增生性肿瘤发展之间的分子联系。这可能对人类造血系统恶性肿瘤有影响,例如骨髓增生异常综合症,该疾病经常表现出miR-146a表达下调。

著录项

  • 作者

    Zhao, Jimmy Liu.;

  • 作者单位

    California Institute of Technology.;

  • 授予单位 California Institute of Technology.;
  • 学科 Biology.;Molecular biology.;Immunology.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 93 p.
  • 总页数 93
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号